(Q51891802)

17 April 2018

title

Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration. (English)

1 reference

17 April 2018

author name string

Vijaykumar Nekkanti

1

1 reference

17 April 2018

Pradeep Karatgi

2

1 reference

17 April 2018

Srinivasarao Paruchuri

3

1 reference

17 April 2018

Raviraj Pillai

4

1 reference

17 April 2018

language of work or name

English

0 references

publication date

10 January 2011

1 reference

17 April 2018

published in

Drug Delivery

1 reference

17 April 2018

volume

18

1 reference

17 April 2018

issue

4

1 reference

17 April 2018

page(s)

294-303

1 reference

17 April 2018

Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

Cyclodextrins as pharmaceutical solubilizers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

Current perspectives on camptothecins in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

1H-NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with alpha-cyclodextrin in the presence of malic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

Camptothecin delivery methods

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

Preparation and antitumor characteristics of PLA/(PEG-PPG-PEG) nanoparticles loaded with camptothecin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

Evaluation of cyclodextrin solubilization of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

Development and characterization of solid oral dosage form incorporating candesartan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

The current status of camptothecin analogues as antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

Isothermal titration calorimetry and 1H NMR studies on host-guest interaction of paeonol and two of its isomers with beta-cyclodextrin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

Clinical applications of the camptothecins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.544689

10.3109/10717544.2010.544689

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018